Welcome to our dedicated page for SOLITRON DEVICES SEC filings (Ticker: SODI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SOLITRON DEVICES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SOLITRON DEVICES's regulatory disclosures and financial reporting.
SOLITRON DEVICES INC (SODI) reported that President and COO Mark Matson completed an "other" acquisition of 3,000 shares of common stock on September 10, 2026, increasing his direct holdings to 241,573 shares. The transaction was executed under a Rule 10b5-1(c) trading plan and his Employment Agreement, which permits quarterly purchases at a weighted average price.
SOLITRON DEVICES INC (SODI) insider reporting involves a sale of common stock by investment entities associated with CEO and 10% owner Howard Timothy Eriksen. On 2026-08-13, entities advised by Eriksen Capital Management LLC sold 500 shares of common stock at $34.70 per share, held indirectly for clients, leaving 271,333 shares reported as indirectly owned. A separate line reports 60,827 shares held directly. The sale is described as part of client portfolio rebalancing and tax planning, with Mr. Eriksen disclaiming beneficial ownership beyond his pecuniary interest.
Solitron Devices Inc. insider-related entities reported a net purchase of common stock. On 2026-08-14, Allens Creek Partners LP purchased 8,000 shares of Solitron common stock at $28.50 per share in a private agreement with Mr. Chiste; the price was agreed before the purchase date and later price changes, and the shares remain subject to an affiliate restriction. After this transaction, entities associated with Eriksen Capital Management LLC (managed by CEO Tim Eriksen) reported 271,833 shares held indirectly and 60,827 shares held directly, with footnotes stating that beneficial ownership is disclaimed except to the extent of pecuniary interest and that voting for certain managed accounts rests with the account owners.
Solitron Devices Inc. director John F. Chiste reported a sale of 8,000 shares of common stock on 2026-08-14 at $28.50 per share in a private agreement with Allens Creek Partners LP. The transaction reduced his directly held common stock position to zero shares, and the shares retain an affiliate restriction after the sale.
Solitron Devices Inc. insider reporting relates to CEO and 10% owner Howard Timothy Eriksen and affiliated entities Eriksen Capital Management LLC (ECM) and Cedar Creek Partners LLC. An investment partnership and ECM-managed accounts sold 563 shares of Solitron Devices common stock on 2026-08-11 at $34.82 per share in a transaction reported as an indirect sale. After this sale, affiliated indirect holdings total 263,833 shares, consisting of 240,341 shares held by Cedar Creek Partners LLC and 23,492 shares held in ECM-managed accounts, where the respective account owners vote the shares. Howard Eriksen also holds 60,827 shares directly. The filing states that the reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest and that the 563-share sale was part of client portfolio rebalancing and tax planning.
Olesen Value Fund L.P., a more-than-10% owner of Solitron Devices, reported selling 1,488 shares of common stock on July 22, 2026 at $29.84 per share. After these sales, the filing reports 216,508 shares of common stock beneficially owned. Related entities Olesen Value Fund GP LLC, Olesen Capital Management LLC and Christian Olesen may be deemed beneficial owners of the fund’s shares, and each disclaims beneficial ownership beyond its or his pecuniary interest.
Olesen Value Fund L.P., together with Olesen Value Fund GP LLC and Christian Olesen, reports beneficial ownership of 216,508 Solitron Devices Inc. common shares, representing approximately 10.1% of the company’s outstanding stock, based on 2,152,703 shares outstanding as of July 10, 2026.
The position, acquired in open‑market transactions for an aggregate purchase price of approximately $811,460 using the fund’s working capital, is held for investment purposes in margin accounts. Olesen Value Fund has sole voting and dispositive power; the GP entity and Christian Olesen share such powers indirectly and disclaim beneficial ownership for other purposes. In the 60 days before July 21, 2026, Olesen Value Fund executed multiple open‑market sales of Solitron Devices shares, including 5,238 shares at $26.60 on June 24, 2026 and 3,366 shares at $29.71 on July 20, 2026. The reporting group states an interest in discussing options for shareholder value creation with Solitron’s management, board, or third parties and may adjust its holdings over time.
Solitron Devices Inc. shareholder Olesen Value Fund L.P., a 10% owner, and related entities reported open-market sales of 24,204 shares of common stock on July 17, 20 and 21, 2026 at prices between $29.56 and $29.82 per share. The filing is joint, and each reporting person disclaims beneficial ownership beyond its pecuniary interest.
Solitron Devices, Inc. reported strong unaudited results for the fiscal 2027 first quarter ended May 31, 2026. Net sales were $5.44 million, up from $2.70 million a year earlier, driving a swing from a net loss of $0.34 million to net income of $0.99 million, or $0.46 per share, compared with a loss of $0.16 per share. Gross profit rose to $2.47 million from $0.39 million, and operating income improved to $1.54 million from a loss of $0.38 million.
Cash and cash equivalents increased to $6.04 million from $3.91 million at February 28, 2026, and total assets were $27.58 million with stockholders’ equity of $20.90 million. Backlog was $23.34 million at quarter-end versus $27.28 million at the beginning of the fiscal year, but a $5.04 million MEI order received after quarter-end brought backlog to $26.97 million as of July 2026. The company highlighted potential demand from a U.S. Air Force request to double AMRAAM missile production by 2028 and noted ongoing exploration of strategic alternatives with an investment banker.
Solitron Devices, Inc. reported a strong turnaround for the three months ended May 31, 2026. Net sales were $5,436,000, up 101% from $2,700,000 a year earlier, driven by higher backlog and scheduled deliveries. Gross profit rose to $2,465,000, with gross margin improving to 45% from 14%.
Operating income was $1,535,000 versus a prior-year operating loss of $378,000. Net income reached $990,000, compared with a net loss of $336,000, and basic and diluted EPS were $0.46. Operating cash flow was $2,171,000, lifting cash and cash equivalents to $6,036,000 and working capital to $10,812,000.
Backlog at May 31, 2026 was $23,341,000, up 28% year over year, although net bookings for the quarter declined 48%. The contingent consideration liability related to the MEI acquisition increased to $1,119,000 due to higher MEI backlog. Management notes a previously identified material weakness in internal control over financial reporting remains, as new controls had not operated long enough to demonstrate effectiveness.